|
Virtual Dictionary
Optogenetic Neuromodulation Optogenetic neuromodulation refers to the process of genetically engineering specific brain cells so they respond to light impulses as if they were electrochemical processes. The field can be used to study the structure of the brain, and to create neural interfaces via grafts of modified brain cells into an existing neural structure. Below, we offer a selection of links from our resource databases which may match this term.
Related Dictionary
Entries for Optogenetic Neuromodulation:
Resources
in our database matching the Term Optogenetic Neuromodulation:
Results by page [1] 
 A new tack in neuroprosthetic interfaces is being born out of pulses of light rather than electricity. Termed 'optogenetic neuromodulation, the technique is being pioneered in the hope that it will enable a far greater level of accuracy and single-cell stimulation than is possible with electrode interfaces.
 A proof of concept set of experiments demonstrates that with the aid of optogenetic neuroprosthetics, memory transferance between individuals is actually possible. This proof of concept also means that encoding downloadable knowledge as a set of memory engram activation patterns is at least possible.
Industry
News containing the Term Optogenetic Neuromodulation:
Results by page (25/02/2010)
Researchers at Medtronic are developing a prototype neural implant that uses light to alter the behavior of neurons in the brain. The device is based on the emerging science of optogenetic neuromodulation, in which specific brain cells are ...
(09/05/2010)
Researchers at four institutions, led by Stanford University and Brown University, have begun an effort with more than $14 million of federal funding to learn both how the brain and its microcircuitry react to sudden physiological changes a...
(24/01/2013)
During a five-hour surgery last October at The Ohio State University Wexner Medical Center, Kathy Sanford became the first Alzheimer’s patient in the United States to have a pacemaker implanted in her brain. She is the first ...
(01/04/2009)
St. Jude Medical is reporting that the company's Libra deep brain stimulation devices have been implanted into initial set of European patients to treat Parkinson's disease. The announcement was made at the European Ass...
(06/12/2009)
St. Jude Medical has received FDA regulatory clearance for the firm's new five-column neurostimulation lead. The Penta?, being unveiled at North American Neuromodulation Society meeting, sports the market's smallest electrodes arranged in...
|
|
|||||||||||||||||||||||||||||||||||||||||||
Bookmark